Page last updated: 2024-10-29

amrinone and Blood Loss, Postoperative

amrinone has been researched along with Blood Loss, Postoperative in 1 studies

Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.

Research Excerpts

ExcerptRelevanceReference
"With the dosage regimen used, supplemented with epinephrine, amrinone provides a higher cardiac output and more favorable oxygen dynamics than a combination of dopamine and nitroglycerin."2.69Amrinone versus dopamine and nitroglycerin in neonates after arterial switch operation for transposition of the great arteries. ( Happonen, JM; Laitinen, P; Peltola, K; Rautiainen, P; Sairanen, H, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Laitinen, P1
Happonen, JM1
Sairanen, H1
Peltola, K1
Rautiainen, P1

Trials

1 trial available for amrinone and Blood Loss, Postoperative

ArticleYear
Amrinone versus dopamine and nitroglycerin in neonates after arterial switch operation for transposition of the great arteries.
    Journal of cardiothoracic and vascular anesthesia, 1999, Volume: 13, Issue:2

    Topics: Adrenergic Agonists; Amrinone; Blood Circulation; Cardiac Output; Cardiopulmonary Bypass; Cardiotoni

1999